Andere talen NeuroOne Medical Technologies Corporation Other OTC

Aandelen

NMTC

US64130M1009

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

NeuroOne Medical Files Shelf Registration For $150 Million Securities Offering	31/05
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14/05
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	14/05
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14	10/05
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	10/04
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	09/04
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04/04
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	26/03
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	26/03
NeuroOne to Participate in the 36th Annual Roth Conference	11/03
NeuroOne® to Participate in the 36th Annual Roth Conference	08/03
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	13/02
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13	08/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	14/12
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update	14/12
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall	11/12
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System	11/12
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System	11/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NeuroOne Medical Technologies Corporation Other OTC

Aandelen

NMTC

US64130M1009

Andere talen

Filters